Tempest Therapeutics, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value
Tempest Therapeutics, Inc. (TPST) had Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value of $5.00 million as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue · last filed 2018-03-15
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value $5.00M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value $10.00M.
- 2017-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value $1.70M.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value $1.30M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value |
|---|---|
| 2017-12-31 | $5.00M 10-K · filed 2018-03-15 |
| 2017-09-30 | $10.00M 10-Q · filed 2017-11-02 |
| 2017-03-31 | $1.70M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.30M 10-K · filed 2017-03-02 |
| 2016-09-30 | $2.60M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $6.60M 10-Q · filed 2016-08-04 |
| 2015-06-30 | $2.20M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |